NASDAQ: LPCNLipocine Inc Stock Ownership - Who owns Lipocine?
Insider buying vs selling
Have Lipocine Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John W. Higuchi | Director | 2026-04-07 | 40,000 | $2.03 | $81.20kBuy |
| John W. Higuchi | Director | 2026-04-06 | 123,000 | $2.05 | $252.15kBuy |
| Mahesh V. Patel | Chief Executive Officer | 2026-04-06 | 25,000 | $2.03 | $50.75kBuy |
| Mahesh V. Patel | Chief Executive Officer | 2026-04-02 | 25,000 | $2.02 | $50.50kBuy |
LPCN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LPCN insiders and whales buy or sell their stock.
LPCN Shareholders
What type of owners hold Lipocine Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Israel Menahem Vizel | 36.39% | 3,000,000 | $6.39M | Insider |
| Visium Balanced Master Fund Ltd | 14.63% | 1,206,000 | $2.57M | Insider |
| William I. Higuchi | 10.82% | 891,876 | $1.90M | Insider |
| Elan Corp PLC | 9.71% | 800,394 | $1.70M | Insider |
| Ucb Manufacturing Ireland Ltd | 7.04% | 580,402 | $1.24M | Insider |
| Ikarian Capital LLC | 6.17% | 508,556 | $1.08M | Institution |
| Squadron Capital Management LLC | 5.46% | 450,000 | $958.50k | Institution |
| Mahesh V. Patel | 4.21% | 347,199 | $739.53k | Insider |
| Eversept Partners LP | 3.58% | 294,989 | $628.33k | Institution |
| John W. Higuchi | 3.18% | 262,275 | $558.65k | Insider |
LPCN vs Biotech Stocks
Lipocine Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.